Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
EASL International Liver Congress (ILC) 2022: virale hepatitis in de spotlights
jul 2022 | Hepatitis, Vaccinatie